Central nervous system syndromes in solid organ transplant recipients

Clin Infect Dis. 2014 Oct;59(7):1001-11. doi: 10.1093/cid/ciu428. Epub 2014 Jun 9.

Abstract

Solid organ transplant recipients have a high incidence of central nervous system (CNS) complications, including both focal and diffuse neurologic deficits. In the immunocompromised host, the initial clinical evaluation must focus on both life-threatening CNS infections and vascular or anatomic lesions. The clinical signs and symptoms of CNS processes are modified by the immunosuppression required to prevent graft rejection. In this population, these etiologies often coexist with drug toxicities and metabolic abnormalities that complicate the development of a specific approach to clinical management. This review assesses the multiple risk factors for CNS processes in solid organ transplant recipients and establishes a timeline to assist in the evaluation and management of these complex patients.

Keywords: central nervous system; fungus; meningitis; organ transplant; virus.

Publication types

  • Review

MeSH terms

  • Case Management / organization & administration
  • Central Nervous System Infections / diagnosis
  • Central Nervous System Infections / drug therapy
  • Central Nervous System Infections / epidemiology*
  • Central Nervous System Infections / pathology
  • Humans
  • Immunocompromised Host*
  • Risk Factors
  • Transplants*